下一个

自动播放

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 意见 • 07/14/23
分享
嵌入
administrator
administrator
订户
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放